News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Accelr8 Technology Corporation (AXK) Names Dr. Matthew Strobeck to Board of Directors


7/11/2012 10:13:17 AM

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Mkt: AXK), a developer of automated diagnostic systems for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens, announced today that Dr. Matthew Strobeck has been appointed to Accelr8's Board of Directors.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES